Expression Vectors Market By Host Type (Bacterial Expression Vectors (E. Coli Expression Vectors, and Other Bacterial Expression Vectors), Mammalian Expression Vectors (CHO Expression Vectors, and Other Mammalian Expression Vectors), Insect Expression Vectors (Baculovirus Expression Vectors, and Other Insect Expression Vectors), Yeast Expression Vectors (K. Lactis Expression Vectors, Pichia Pastoris Expression Vectors, Saccharomyces Cerevisiae Expression Vectors, and Other Yeast Expression Vectors), and Other Expression Vectors), By Application (Therapeutic Applications, Research Applications, and Industrial Applications), By End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations (Cros) and Contract Manufacturing Organizations (Cmos), Academic Research Institutes, and Other End Users), and By Region - Trends, Analysis and Forecast till 2034

Report Code: PMI386920 | Publish Date: May 2024 | No. of Pages: 180

Global Expression Vectors Market Market Companies

  • Thermo Fisher Scientific
  • Sigma-Aldrich Corporation
  • Agilent Technologies
  • Promega Corporation
  • Bio-Rad Laboratories
  • LineRx
  • Life Technologies Corporation
  • Clontech Laboratories Inc.
  • Merck Millipore
  • Qiagen.

Recent News:

  • In September 20, 2023, Ingenuity in for the production of large and complex proteins, the baculovirus–insect cell expression system (BEVS), which combines insect cells with the baculovirus expression vector system, is still an essential technology. This eukaryotic expression system provides built-in safety, simple scaling up, adaptable product design, and versatility for a wide variety of proteins.
  • Lonza introduced its new GS Effex cell line in November 2023 to create therapeutic antibodies with increased potency. The GS Effex cell line fills urgent market demands as therapeutic antibodies become more sophisticated. GS Effex, which is derived from Lonza's top-performing GS Xceed cell line, integrates well with Lonza platforms.